These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35593652)

  • 1. Hijacking of Cellular Functions by Severe Acute Respiratory Syndrome Coronavirus-2. Permeabilization and Polarization of the Host Lipid Membrane by Viroporins.
    Bignon E; Marazzi M; Monari A
    J Phys Chem Lett; 2022 Jun; 13(21):4642-4649. PubMed ID: 35593652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viroporins: Structure, function, and their role in the life cycle of SARS-CoV-2.
    Breitinger U; Farag NS; Sticht H; Breitinger HG
    Int J Biochem Cell Biol; 2022 Apr; 145():106185. PubMed ID: 35219876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Channel activity of SARS-CoV-2 viroporin ORF3a inhibited by adamantanes and phenolic plant metabolites.
    Fam MS; Sedky CA; Turky NO; Breitinger HG; Breitinger U
    Sci Rep; 2023 Apr; 13(1):5328. PubMed ID: 37005439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 ORF3a induces RETREG1/FAM134B-dependent reticulophagy and triggers sequential ER stress and inflammatory responses during SARS-CoV-2 infection.
    Zhang X; Yang Z; Pan T; Long X; Sun Q; Wang PH; Li X; Kuang E
    Autophagy; 2022 Nov; 18(11):2576-2592. PubMed ID: 35239449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unravelling the Immunomodulatory Effects of Viral Ion Channels, towards the Treatment of Disease.
    Gargan S; Stevenson NJ
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34834972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway.
    Xu H; Akinyemi IA; Chitre SA; Loeb JC; Lednicky JA; McIntosh MT; Bhaduri-McIntosh S
    Virology; 2022 Mar; 568():13-22. PubMed ID: 35066302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis.
    Castaño-Rodriguez C; Honrubia JM; Gutiérrez-Álvarez J; DeDiego ML; Nieto-Torres JL; Jimenez-Guardeño JM; Regla-Nava JA; Fernandez-Delgado R; Verdia-Báguena C; Queralt-Martín M; Kochan G; Perlman S; Aguilella VM; Sola I; Enjuanes L
    mBio; 2018 May; 9(3):. PubMed ID: 29789363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SARS-CoV-2 accessory protein Orf3a is not an ion channel, but does interact with trafficking proteins.
    Miller AN; Houlihan PR; Matamala E; Cabezas-Bratesco D; Lee GY; Cristofori-Armstrong B; Dilan TL; Sanchez-Martinez S; Matthies D; Yan R; Yu Z; Ren D; Brauchi SE; Clapham DE
    Elife; 2023 Jan; 12():. PubMed ID: 36695574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ORF3a of SARS-CoV-2 promotes lysosomal exocytosis-mediated viral egress.
    Chen D; Zheng Q; Sun L; Ji M; Li Y; Deng H; Zhang H
    Dev Cell; 2021 Dec; 56(23):3250-3263.e5. PubMed ID: 34706264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 ORF3a-Mediated NF-κB Activation Is Not Dependent on TRAF-Binding Sequence.
    Busscher BM; Befekadu HB; Liu Z; Xiao TS
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ORF3a mutation associated with higher mortality rate in SARS-CoV-2 infection.
    Majumdar P; Niyogi S
    Epidemiol Infect; 2020 Oct; 148():e262. PubMed ID: 33100263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico identification of Tretinoin as a SARS-CoV-2 envelope (E) protein ion channel inhibitor.
    Dey D; Borkotoky S; Banerjee M
    Comput Biol Med; 2020 Dec; 127():104063. PubMed ID: 33126128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the YXXΦ Motifs of the SARS Coronaviruses 1 and 2 ORF3a Peptides by In Silico Analysis to Predict Novel Virus-Host Interactions.
    Kakkanas A; Karamichali E; Koufogeorgou EI; Kotsakis SD; Georgopoulou U; Foka P
    Biomolecules; 2022 Jul; 12(8):. PubMed ID: 36008946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial Damage by SARS-CoV-2: Emerging Mechanisms and Therapies.
    Ho HT; Peischard S; Strutz-Seebohm N; Klingel K; Seebohm G
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaustive mutational analysis of severe acute respiratory syndrome coronavirus 2 ORF3a: An essential component in the pathogen's infectivity cycle.
    Benazraf A; Arkin IT
    Protein Sci; 2023 Jan; 32(1):e4528. PubMed ID: 36468608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of accessory protein variants in the pathogenicity of SARS-CoV-2.
    Hassan SS; Choudhury PP; Dayhoff GW; Aljabali AAA; Uhal BD; Lundstrom K; Rezaei N; Pizzol D; Adadi P; Lal A; Soares A; Mohamed Abd El-Aziz T; Brufsky AM; Azad GK; Sherchan SP; Baetas-da-Cruz W; Takayama K; Serrano-Aroca Ã; Chauhan G; Palu G; Mishra YK; Barh D; Santana Silva RJ; Andrade BS; Azevedo V; Góes-Neto A; Bazan NG; Redwan EM; Tambuwala M; Uversky VN
    Arch Biochem Biophys; 2022 Mar; 717():109124. PubMed ID: 35085577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of autophagy by SARS-CoV-2: The multifunctional contributions of ORF3a.
    Shariq M; Malik AA; Sheikh JA; Hasnain SE; Ehtesham NZ
    J Med Virol; 2023 Jul; 95(7):e28959. PubMed ID: 37485696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 ORF3a Induces Incomplete Autophagy via the Unfolded Protein Response.
    Su WQ; Yu XJ; Zhou CM
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic perspective of missense mutations of ORF3a protein of SARS-CoV-2.
    Hassan SS; Attrish D; Ghosh S; Choudhury PP; Roy B
    Virus Res; 2021 Jul; 300():198441. PubMed ID: 33940003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SARS-CoV-2 accessory protein Orf3a is not an ion channel, but does interact with trafficking proteins.
    Miller AN; Houlihan PR; Matamala E; Cabezas-Bratesco D; Lee GY; Cristofori-Armstrong B; Dilan TL; Sanchez-Martinez S; Matthies D; Yan R; Yu Z; Ren D; Brauchi SE; Clapham DE
    bioRxiv; 2022 Sep; ():. PubMed ID: 36263072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.